Cargando…

Profile of treatment-related complications in women with clinical stage IB-IIB cervical cancer: A nationwide cohort study in Japan

OBJECTIVE: To examine clinico-pathological factors associated with surgical complications and postoperative therapy for clinical stage IB-IIB cervical cancer. METHODS: This nationwide multicenter retrospective study examined women with clinical stage IB-IIB cervical cancer who underwent radical hyst...

Descripción completa

Detalles Bibliográficos
Autores principales:	Machida, Hiroko, Matsuo, Koji, Furusawa, Akiko, Kita, Tsunekazu, Kitagawa, Ryo, Mikami, Mikio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322763/ https://www.ncbi.nlm.nih.gov/pubmed/30615679 http://dx.doi.org/10.1371/journal.pone.0210125

Ejemplares similares

Ovarian conservation for young women with clinical stage IB–IIB cervical cancer in Japan
por: Matsuo, Koji, et al.
Publicado: (2017)

Quality and quantity metrics of pelvic lymph node metastasis and risk of para-aortic lymph node metastasis in stage IB–IIB cervical cancer
por: Matsuo, Koji, et al.
Publicado: (2018)

Risk stratification models for para-aortic lymph node metastasis and recurrence in stage IB–IIB cervical cancer
por: Matsuo, Koji, et al.
Publicado: (2018)

Trachelectomy for stage IB1 cervical cancer with tumor size >2 cm: trends and characteristics in the United States
por: Matsuo, Koji, et al.
Publicado: (2018)

Comparison of treatment outcomes of surgery and radiotherapy, including concurrent chemoradiotherapy for stage Ib2-IIb cervical adenocarcinoma patients: a retrospective study
por: Kondo, Eiji, et al.
Publicado: (2021)

Neoadjuvant Chemotherapy with Taxane and Platinum Followed by Radical Hysterectomy for Stage IB2-IIB Cervical Cancer: Impact of Histology Type on Survival
por: Matsuo, Koji, et al.
Publicado: (2019)

Neoadjuvant chemotherapy for epithelial ovarian cancer in Japan: a JSGO-JSOG joint study
por: Machida, Hiroko, et al.
Publicado: (2019)

Effectiveness of adjuvant systemic chemotherapy for intermediate-risk stage IB cervical cancer
por: Matsuo, Koji, et al.
Publicado: (2017)

Practice patterns of adjuvant therapy for intermediate/high recurrence risk cervical cancer patients in Japan
por: Ikeda, Yuji, et al.
Publicado: (2016)

Significance of histology and nodal status on the survival of women with early-stage cervical cancer: validation of the 2018 FIGO cervical cancer staging system
por: Machida, Hiroko, et al.
Publicado: (2022)

Trend and characteristics of minimally invasive surgery for patients with endometrial cancer in Japan
por: Yoshida, Hiroshi, et al.
Publicado: (2023)

The Prognostic Impact of Grading in FIGO IB and IIB Squamous Cell Cervical Carcinomas
por: Brambs, Christine E., et al.
Publicado: (2019)

Significance of Malignant Peritoneal Cytology on the Survival of Women with Early-Stage Cervical Cancer: A Japanese Gynecologic Oncology Group Study
por: Matsuo, Koji, et al.
Publicado: (2019)

The prognosis of women with stage IB1-IIB node-positive cervical carcinoma after radical surgery
por: Cheng, Xi, et al.
Publicado: (2004)

Risk model in stage IB1-IIB cervical cancer with positive node after radical hysterectomy
por: Chen, Zhilan, et al.
Publicado: (2016)

A Fifteen‐Gene Classifier to Predict Neoadjuvant Chemotherapy Responses in Patients with Stage IB to IIB Squamous Cervical Cancer
por: Tian, Xun, et al.
Publicado: (2021)

Association between hospital treatment volume and survival of women with gynecologic malignancy in Japan: a JSOG tumor registry-based data extraction study
por: Machida, Hiroko, et al.
Publicado: (2021)

Surgically treated cervical cancer in a high-risk group in the era of the 2018 FIGO staging schema: a nationwide study
por: Shigeta, Shogo, et al.
Publicado: (2023)

Pretreatment Systemic Immune-Inflammation Index Can Predict Response to Neoadjuvant Chemotherapy in Cervical Cancer at Stages IB2-IIB
por: Liu, Pingping, et al.
Publicado: (2022)

Wait-time for adjuvant radiotherapy and oncologic outcome in early-stage cervical cancer: A treatment implication during the coronavirus pandemic
por: Matsuo, Koji, et al.
Publicado: (2021)

Contribution of pelvic and para-aortic lymphadenectomy with sentinel node biopsy in patients with IB2–IIB cervical cancer
por: Chéreau, E, et al.
Publicado: (2012)

Prognostic risk model development and prospective validation among patients with cervical cancer stage IB2 to IIB submitted to neoadjuvant chemotherapy
por: Huang, Kecheng, et al.
Publicado: (2016)

Intraoperative Capsule Rupture, Postoperative Chemotherapy, and Survival of Women With Stage I Epithelial Ovarian Cancer
por: Matsuo, Koji, et al.
Publicado: (2019)

Comment on ‘Contribution of pelvic and para-aortic lymphadenectomy with sentinel node biopsy in patients with IB2–IIB cervical cancer’
por: Peres, A, et al.
Publicado: (2012)

Assessment of local treatment modalities for FIGO stage IB-IIB cervical cancer: A propensity-score matched analysis based on SEER database
por: Song, Xing, et al.
Publicado: (2017)

The Effect of Neoadjuvant Chemotherapy on Lymph Node Metastasis of FIGO Stage IB1-IIB Cervical Cancer: A Systematic Review and Meta-Analysis
por: Chen, Bingxin, et al.
Publicado: (2020)

Neoadjuvant chemotherapy plus surgery versus concurrent chemoradiotherapy in stage IB2-IIB cervical cancer: A systematic review and meta-analysis
por: Zou, Wen, et al.
Publicado: (2019)

Reply: Comment on ‘Contribution of pelvic and para-aortic lymphadenectomy with sentinel node biopsy in patients with IB2–IIB cervical cancer’
por: Chéreau, E, et al.
Publicado: (2012)

Optimal pathological response indicated better long-term outcome among patients with stage IB2 to IIB cervical cancer submitted to neoadjuvant chemotherapy
por: Huang, Kecheng, et al.
Publicado: (2016)

Neoadjuvant chemotherapy followed by surgery has no therapeutic advantages over concurrent chemoradiotherapy in International Federation of Gynecology and Obstetrics stage IB-IIB cervical cancer
por: Lee, Jeongshim, et al.
Publicado: (2016)

Neoadjuvant chemotherapy for locally advanced stage (IB2-IIA2-IIB) cervical carcinoma: Experience of a tertiary center and comprehensive review of the literature
por: Çakır, Caner, et al.
Publicado: (2021)

Analysis of pathological and clinical characteristics of cervical conization according to age group in Japan
por: Murakami, Isao, et al.
Publicado: (2020)

Utility of Comprehensive Serum Glycopeptide Spectra Analysis (CSGSA) for the Detection of Early Stage Epithelial Ovarian Cancer
por: Matsuo, Koji, et al.
Publicado: (2020)

Changes in the Clinicopathological Demographics of Vulvar Cancer in Japan: Increasing Oldest-Old, Stage Shifting, and Decreasing Cohort-Level Survival †
por: Nishio, Shin, et al.
Publicado: (2019)

Trends in single women with malignancy of the uterine cervix in United States
por: Machida, Hiroko, et al.
Publicado: (2018)

Comprehensive Serum Glycopeptide Spectra Analysis Combined with Artificial Intelligence (CSGSA-AI) to Diagnose Early-Stage Ovarian Cancer
por: Tanabe, Kazuhiro, et al.
Publicado: (2020)

Impact of COVID-19 on gynecologic cancer treatment in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)
por: Nogami, Yuya, et al.
Publicado: (2021)

Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgery
por: Miller, Heather, et al.
Publicado: (2021)

Neoadjuvant Chemotherapy Followed by Radical Surgery versus Radiotherapy (with or without Chemotherapy) in Patients with Stage IB2, IIA, or IIB Cervical Cancer: A Systematic Review and Meta-Analysis
por: Ye, Qingjian, et al.
Publicado: (2020)

CLPTM1L expression predicts recurrence of patients with intermediate‑ and high‑risk stage IB‑IIB cervical cancer undergoing radical hysterectomy followed by TP as adjuvant chemotherapy
por: Awazu, Yuichiro, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fu4gn361483crvibibhfu516ql